José Luis Vizmanos
José Luis Vizmanos
Catedrático, Área de Genética
Geverifieerd e-mailadres voor unav.es
Titel
Geciteerd door
Geciteerd door
Jaar
Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1
D Garcia-Yoldi, CM Marín, MJ de Miguel, PM Munoz, JL Vizmanos, ...
Clinical chemistry 52 (4), 779-781, 2006
2222006
Novel translocations that disrupt the platelet‐derived growth factor receptor β (PDGFRB) gene in BCR–ABL‐negative chronic myeloproliferative disorders
EJ Baxter, S Kulkarni, JL Vizmanos, R Jaju, G Martinelli, N Testoni, ...
British journal of haematology 120 (2), 251-256, 2003
1082003
Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients
X Agirre, JL Vizmanos, MJ Calasanz, M García-Delgado, MJ Larráyoz, ...
Oncogene 22 (7), 1070-1072, 2003
882003
Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions
M Shugay, I Ortiz de Mendíbil, JL Vizmanos, FJ Novo
Bioinformatics 29 (20), 2539-2546, 2013
842013
TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia
X Agirre, FJ Novo, MJ Calasanz, MJ Larráyoz, I Lahortiga, M Valgañón, ...
Molecular Carcinogenesis: Published in cooperation with the University of …, 2003
812003
TICdb: a collection of gene-mapped translocation breakpoints in cancer
FJ Novo, IO de Mendíbil, JL Vizmanos
BMC genomics 8 (1), 1-5, 2007
802007
Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies
MD Odero, FH Grand, S Iqbal, F Ross, JP Roman, JL Vizmanos, ...
Leukemia 19 (2), 245-252, 2005
792005
NIN, a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to PDGFRB in a Patient with at (5; 14)(q33; q24) and an Imatinib-Responsive Myeloproliferative Disorder 1
JL Vizmanos, FJ Novo, JP Román, EJ Baxter, I Lahortiga, MJ Larráyoz, ...
Cancer research 64 (8), 2673-2676, 2004
782004
JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients
JL Vizmanos, C Ormazábal, MJ Larrayoz, NCP Cross, MJ Calasanz
Leukemia 20 (3), 534-535, 2006
632006
Clinical variability of patients with the t (6; 8)(q27; p12) and FGFR1OP-FGFR1 fusion: two further cases.
JL Vizmanos, R Hernández, MJ Vidal, MJ Larráyoz, MD Odero, J Marín, ...
The hematology journal: the official journal of the European Haematology …, 2004
602004
Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements
I Lahortiga, I Vázquez, X Agirre, MJ Larrayoz, JL Vizmanos, A Gozzetti, ...
Genes, Chromosomes and Cancer 40 (3), 179-189, 2004
592004
NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t (10; 11)(q25; p15)
I Lahortiga, JL Vizmanos, X Agirre, I Vázquez, JC Cigudosa, MJ Larrayoz, ...
Cancer Research 63 (12), 3079-3083, 2003
472003
Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse …
P Bolufer, FL Coco, D Grimwade, E Barragán, D Diverio, B Cassinat, ...
Haematologica 86 (6), 570-576, 2001
412001
t(10;16)(q22;p13) and MORFCREBBP fusion is a recurrent event in acute myeloid leukemia
JL Vizmanos, MJ Larráyoz, I Lahortiga, F Floristán, C Alvarez, MD Odero, ...
Genes, Chromosomes and Cancer 36 (4), 402-405, 2003
382003
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome
MD Odero, JL Vizmanos, JP Román, I Lahortiga, C Panizo, MJ Calasanz, ...
Genes, Chromosomes and Cancer 35 (1), 11-19, 2002
382002
Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase
Á Cuesta-Domínguez, M Ortega, C Ormazábal, M Santos-Roncero, ...
PLoS One 7 (2), e32451, 2012
322012
Phenolic compounds inhibit 3T3-L1 adipogenesis depending on the stage of differentiation and their binding affinity to PPARγ
P Aranaz, D Navarro-Herrera, M Zabala, I Miguéliz, A Romo-Hualde, ...
Molecules 24 (6), 1045, 2019
292019
Genomic hallmarks of genes involved in chromosomal translocations in hematological cancer
M Shugay, I Ortiz de Mendibil, JL Vizmanos, FJ Novo
PLoS computational biology 8 (12), e1002797, 2012
282012
Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping
A Martı́nez-Ramı́rez, M Urioste, S Alvarez, JL Vizmanos, MJ Calasanz, ...
Cancer genetics and cytogenetics 153 (1), 39-47, 2004
282004
Degree and distribution of variability in the 5'untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV)
JL Vizmanos, CJ González‐Navarro, FJ Novo, MP Civeira, J Prieto, ...
Journal of viral hepatitis 5 (4), 227-240, 1998
261998
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20